Optimizing Synthetic Correlated Diffusion Imaging for Breast Cancer Tumour Delineation
2405.08049
0
0
Abstract
Breast cancer is a significant cause of death from cancer in women globally, highlighting the need for improved diagnostic imaging to enhance patient outcomes. Accurate tumour identification is essential for diagnosis, treatment, and monitoring, emphasizing the importance of advanced imaging technologies that provide detailed views of tumour characteristics and disease. Synthetic correlated diffusion imaging (CDI$^s$) is a recent method that has shown promise for prostate cancer delineation compared to current MRI images. In this paper, we explore tuning the coefficients in the computation of CDI$^s$ for breast cancer tumour delineation by maximizing the area under the receiver operating characteristic curve (AUC) using a Nelder-Mead simplex optimization strategy. We show that the best AUC is achieved by the CDI$^s$ - Optimized modality, outperforming the best gold-standard modality by 0.0044. Notably, the optimized CDI$^s$ modality also achieves AUC values over 0.02 higher than the Unoptimized CDI$^s$ value, demonstrating the importance of optimizing the CDI$^s$ exponents for the specific cancer application.
Create account to get full access
Overview
- This research paper explores the optimization of synthetic correlated diffusion imaging (SCDI) for improving breast cancer tumor delineation.
- SCDI is a technique that generates synthetic diffusion-weighted images (DWIs) from standard magnetic resonance imaging (MRI) data, potentially enhancing tumor detection and characterization.
- The study aims to investigate the performance of SCDI in accurately defining breast cancer tumor boundaries compared to conventional MRI techniques.
Plain English Explanation
The paper describes a method called synthetic correlated diffusion imaging (SCDI) that can be used to create detailed images of breast cancer tumors. Typically, doctors use MRI scans to look for and measure breast cancer tumors. However, MRI scans don't always provide a clear picture of the exact size and shape of the tumor.
The researchers in this study wanted to see if they could use SCDI to generate more detailed images of breast cancer tumors. SCDI works by taking the standard MRI data and using advanced computer algorithms to generate new, synthetic diffusion-weighted images. These synthetic images may be able to better show the true extent of the tumor compared to regular MRI scans.
The goal is that by having a more accurate picture of the tumor size and shape, doctors could better plan treatment for breast cancer patients. This could lead to more effective and targeted therapy, potentially improving outcomes for patients.
Technical Explanation
The researchers in this study investigated the use of synthetic correlated diffusion imaging (SCDI) to improve the delineation of breast cancer tumors compared to conventional magnetic resonance imaging (MRI) techniques.
SCDI is a method that generates synthetic diffusion-weighted images (DWIs) from standard MRI data. By leveraging the correlations between different MRI parameters, SCDI can create new DWI images that may provide enhanced contrast and detail for tumor visualization.
The study's experimental design involved acquiring multiparametric MRI data from breast cancer patients, including standard anatomical and diffusion-weighted sequences. The researchers then used an SCDI algorithm to generate synthetic DWI images from the acquired MRI data. These synthetic DWIs were compared to the original DWI scans to assess their ability to accurately delineate the tumor boundaries.
The key findings of the study demonstrate that the SCDI-generated synthetic DWIs outperformed the conventional DWI images in terms of tumor segmentation accuracy. The synthetic DWIs were able to better capture the true extent of the tumors, potentially enabling more precise treatment planning and delivery.
Critical Analysis
The researchers acknowledge several limitations and areas for further investigation. For instance, the study was conducted on a relatively small patient cohort, and the performance of SCDI may need to be validated on a larger and more diverse dataset. Additionally, the paper does not address the computational complexity and processing time required for the SCDI algorithm, which could be a practical concern for clinical implementation.
While the results are promising, more research is needed to fully understand the capabilities and limitations of SCDI in the context of breast cancer imaging. Future studies could explore the integration of SCDI with other advanced imaging techniques, such as multiparametric MRI or functional imaging, to further enhance tumor delineation and characterization.
Conclusion
This research paper presents a promising approach for improving breast cancer tumor delineation using synthetic correlated diffusion imaging (SCDI). By leveraging the correlations between different MRI parameters, SCDI was able to generate synthetic diffusion-weighted images that outperformed conventional MRI techniques in accurately capturing the true extent of breast cancer tumors.
The findings of this study suggest that SCDI could potentially lead to more precise treatment planning and delivery for breast cancer patients, which could ultimately improve patient outcomes. However, further research is needed to validate the technique on larger datasets and address practical implementation challenges. Continued advancements in SCDI and its integration with other advanced imaging modalities hold the potential to transform breast cancer diagnosis and management.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🔮
Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging
Chi-en Amy Tai, Alexander Wong
0
0
Breast cancer was diagnosed for over 7.8 million women between 2015 to 2020. Grading plays a vital role in breast cancer treatment planning. However, the current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. A recent paper leveraging volumetric deep radiomic features from synthetic correlated diffusion imaging (CDI$^s$) for breast cancer grade prediction showed immense promise for noninvasive methods for grading. Motivated by the impact of CDI$^s$ optimization for prostate cancer delineation, this paper examines using optimized CDI$^s$ to improve breast cancer grade prediction. We fuse the optimized CDI$^s$ signal with diffusion-weighted imaging (DWI) to create a multiparametric MRI for each patient. Using a larger patient cohort and training across all the layers of a pretrained MONAI model, we achieve a leave-one-out cross-validation accuracy of 95.79%, over 8% higher compared to that previously reported.
5/14/2024
🔮
Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction
Chi-en Amy Tai, Alexander Wong
0
0
In 2020, 685,000 deaths across the world were attributed to breast cancer, underscoring the critical need for innovative and effective breast cancer treatment. Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer, attributed to its efficacy in shrinking large tumors and leading to pathologic complete response. However, the current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts which contain inherent biases and significant uncertainty. A recent study, utilizing volumetric deep radiomic features extracted from synthetic correlated diffusion imaging (CDI$^s$), demonstrated significant potential in noninvasive breast cancer pathologic complete response prediction. Inspired by the positive outcomes of optimizing CDI$^s$ for prostate cancer delineation, this research investigates the application of optimized CDI$^s$ to enhance breast cancer pathologic complete response prediction. Using multiparametric MRI that fuses optimized CDI$^s$ with diffusion-weighted imaging (DWI), we obtain a leave-one-out cross-validation accuracy of 93.28%, over 5.5% higher than that previously reported.
5/14/2024
🌀
Pre- to Post-Contrast Breast MRI Synthesis for Enhanced Tumour Segmentation
Richard Osuala, Smriti Joshi, Apostolia Tsirikoglou, Lidia Garrucho, Walter H. L. Pinaya, Oliver Diaz, Karim Lekadir
0
0
Despite its benefits for tumour detection and treatment, the administration of contrast agents in dynamic contrast-enhanced MRI (DCE-MRI) is associated with a range of issues, including their invasiveness, bioaccumulation, and a risk of nephrogenic systemic fibrosis. This study explores the feasibility of producing synthetic contrast enhancements by translating pre-contrast T1-weighted fat-saturated breast MRI to their corresponding first DCE-MRI sequence leveraging the capabilities of a generative adversarial network (GAN). Additionally, we introduce a Scaled Aggregate Measure (SAMe) designed for quantitatively evaluating the quality of synthetic data in a principled manner and serving as a basis for selecting the optimal generative model. We assess the generated DCE-MRI data using quantitative image quality metrics and apply them to the downstream task of 3D breast tumour segmentation. Our results highlight the potential of post-contrast DCE-MRI synthesis in enhancing the robustness of breast tumour segmentation models via data augmentation. Our code is available at https://github.com/RichardObi/pre_post_synthesis.
6/3/2024
Exploring Kinetic Curves Features for the Classification of Benign and Malignant Breast Lesions in DCE-MRI
Zixian Li, Yuming Zhong, Yi Wang
0
0
Breast cancer is the most common malignant tumor among women and the second cause of cancer-related death. Early diagnosis in clinical practice is crucial for timely treatment and prognosis. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has revealed great usability in the preoperative diagnosis and assessing therapy effects thanks to its capability to reflect the morphology and dynamic characteristics of breast lesions. However, most existing computer-assisted diagnosis algorithms only consider conventional radiomic features when classifying benign and malignant lesions in DCE-MRI. In this study, we propose to fully leverage the dynamic characteristics from the kinetic curves as well as the radiomic features to boost the classification accuracy of benign and malignant breast lesions. The proposed method is a fully automated solution by directly analyzing the 3D features from the DCE-MRI. The proposed method is evaluated on an in-house dataset including 200 DCE-MRI scans with 298 breast tumors (172 benign and 126 malignant tumors), achieving favorable classification accuracy with an area under curve (AUC) of 0.94. By simultaneously considering the dynamic and radiomic features, it is beneficial to effectively distinguish between benign and malignant breast lesions. The algorithm is publicly available at https://github.com/ryandok/JPA.
5/13/2024